NCT06266975Not yet recruiting
Chronic Kidney Disease Patient in Chronic Myloied Leukemia
Source: ClinicalTrials.gov · Last updated 20 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To study the Prevalence ,Characteristics and outcome of CKD in patiants with chronic myeloid leukemia .
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 3 Nov 2023
- Start date
- Feb 2024
- Primary completion date
- Nov 2026
- Lead sponsor
- Sahar Mohammed Gad
- NCT number
- NCT06266975
What you commit to
- Study type: Observational
- Planned participants: 40
- From Feb 2024 to the primary completion date, Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- \-
- Exclusion : 1\_pts known to have CKD before diagnosed of CML. 2- known Diabetic pts 3-imaging suggestive CKD etiology rather than CML effect eg.PKD,renal stones,chronic pyelonephritis
Age in the registry: 18 years to 75 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.